---
brand_name: "ALTOPREV"
generic_name: "LOVASTATIN"
slug: "lovastatin--release-oral-10mg"
canonical_url: "https://medichelpline.com/drug-index/lovastatin--release-oral-10mg"
content_type: "drug_monograph"
route: "ORAL"
drug_class: "Cardiovascular"
fda_updated_at: "2024-03-14T00:00:00.000Z"
license: "Drugs@FDA Public Domain / Informational Use"
---
# ALTOPREV (LOVASTATIN)
## Clinical Monograph Metadata
- **Canonical URL:** https://medichelpline.com/drug-index/lovastatin--release-oral-10mg
- **Generic / Active Ingredient:** LOVASTATIN
- **Brand Name:** ALTOPREV
- **Administration Route:** ORAL
- **Pharmacological Class:** Cardiovascular
- **FDA Data Timestamp:** 2024-03-14T00:00:00.000Z
## Primary Indication & Clinical Use
Review priority: STANDARD Marketing status: Discontinued
## Monograph Summary

Approval overview ALTOPREV is listed in Drugs@FDA under application 021316 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LOVASTATIN Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG Sponsor AZURITY Submission history Latest submission status date: 2024-03-14 00:00:00. Submission type: SUPPL.

## Primary Sources & FDA Regulatory Records
- [Drugs@FDA Primary Database](https://www.accessdata.fda.gov/scripts/cder/daf/) (Reference Slug: `lovastatin--release-oral-10mg`)
## Navigation
- [← Back to Drug Index Hub](https://medichelpline.com/drug-index.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.